Clinical Trial Update: Study of AK119 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

The Phase 1 study of AK119 in subjects with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AK119

Snippet

Sponsor: Akeso | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED